文献速递炎症性肠病

系统综述与Meta分析:抑郁状态对成人炎症性肠病疾病进程的影响

Systematic review with meta-analysis: the impact of a depressive state on disease course in adult inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2017-06-02

该系统综述与Meta分析纳入11项前瞻性研究、共3194例成人炎症性肠病(IBD)患者,评估基线抑郁状态对后续疾病进程的影响。5项研究报告抑郁状态与疾病进程存在关联,溃疡性结肠炎(UC)专项研究均未发现关联,克罗恩病(CD)专项研究4项中3项发现关联。基线临床缓解患者的汇总分析未发现关联(HR 1.04,95%CI:0.97-1.12)。

要点

  • 5项研究报告抑郁状态与IBD疾病进程相关,UC专项研究均未发现关联。
  • CD专项研究4项中3项报告抑郁状态与疾病进程恶化相关。
  • 基线临床缓解患者汇总分析未发现关联(HR 1.04,95%CI:0.97-1.12)。

核心结论

  • 支持抑郁状态与IBD后续疾病进程恶化相关的证据有限,但现有数据更支持其与CD而非UC的关联。
  • 基线疾病活动度可能是该关联中的重要因素。
  • 需要进一步研究以理解心理健康与IBD结局之间的关系。

研究设计与样本

  • 系统综述,检索MEDLINE、EMBASE、Cochrane系统综述数据库和PsychINFO,纳入评估基线抑郁状态对成人IBD后续疾病进程影响的前瞻性研究。
  • 共纳入11项研究,代表3194例IBD患者。
  • 3项研究仅报告UC患者,4项研究仅纳入CD患者,4项研究同时纳入UC和CD患者。

主要发现

  • 5项研究报告抑郁状态与疾病进程存在关联。
  • UC专项研究均未发现任何关联。
  • CD专项研究4项中3项发现抑郁状态与疾病进程恶化之间存在关联。
  • 5项纳入基线缓解患者的研究中4项未发现抑郁状态与疾病进程的关联。
  • 对基线临床缓解IBD患者的汇总分析未发现抑郁状态与疾病进程的关联(HR 1.04,95%CI:0.97-1.12)。

局限性

  • 支持抑郁状态与IBD后续疾病进程恶化相关的证据有限。
  • 需要进一步研究以理解心理健康与IBD结局之间的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite a higher prevalence of psychosocial morbidity in Inflammatory Bowel Disease (IBD), the association between depressive state and disease course in IBD is poorly understood. AIM: To investigate the impact of depressive state on disease course in IBD. METHODS: We conducted a systematic review in MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews and PsychINFO for prospective studies evaluating the impact of baseline depressive state on subsequent disease course in adult IBD. RESULTS: Eleven studies matched our entry criteria, representing 3194 patients with IBD. Three reported on patients with ulcerative colitis (UC), four included patients with Crohn's disease (CD) exclusively, and four studies included both UC and CD. Five studies reported an association between depressive state and disease course. None of the UC-specific studies found any association. In three of four CD-specific studies, a relationship between depressive state and worsening disease course was found. In four of five studies including patients in remission at baseline, no association between depressive state and disease course was found. Pooled analysis of IBD studies with patients in clinical remission at baseline identified no association between depressive state and disease course (HR 1.04, 95%CI: 0.97-1.12). CONCLUSION: There is limited evidence to support an association between depressive state and subsequent deterioration in disease course in IBD, but what data that exist are more supportive of an association with CD than UC. Baseline disease activity may be an important factor in this relationship. Further studies are needed to understand the relationship between mental health and outcomes in IBD.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Alexakis C, Kumar S, Saxena S, et al. Systematic review with meta-analysis: the impact of a depressive state on disease course in adult inflammatory bowel disease. Aliment Pharmacol Ther. 2017. PMID: 28573652. doi:10.1111/apt.14171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。